Home › Funds › Green Alpha Advisors, LLC › MRNA
Green Alpha Advisors, LLC position in MRNA
MODERNA INC · Health Care
Green Alpha Advisors, LLC reported holding 33,191 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$6.4M, representing 4.33% of its reported portfolio and ranking #4 among its reported holdings. Green Alpha Advisors, LLC has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How Green Alpha Advisors, LLC's MRNA position evolved
Green Alpha Advisors, LLC first disclosed a stake in MRNA in Q3 2023 at 11,731 shares (US$1.2M). The position peaked in Q3 2026 at 33,191 shares, worth US$6.4M. Across 13 filings, Green Alpha Advisors, LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 33,191 shares valued at US$6.4M — a reduction of -567 shares quarter over quarter.. Notable position changes include a 55% increase in Q4 2024 (shares fell 32% over the following quarter), a 70% increase in Q1 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 11.73K | $1.21M | New |
| Q4 2023 | 11.60K | $1.15M | Reduce |
| Q1 2024 | 12.95K | $1.38M | Add |
| Q2 2024 | 10.28K | $1.22M | Reduce |
| Q3 2024 | 10.91K | $729.32K | Add |
| Q4 2024 | 16.90K | $702.70K | Add |
| Q1 2025 | 28.67K | $812.91K | Add |
| Q2 2025 | 31.27K | $862.77K | Add |
| Q3 2025 | 28.14K | $726.88K | Reduce |
| Q4 2025 | 33.16K | $977.77K | Add |
| Q1 2026 | 34.34K | $1.74M | Add |
| Q2 2026 | 33.76K | $2.36M | Reduce |
| Q3 2026 | 33.19K | $6.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 37 other funds we track also report a position in MRNA — the largest reported positions include Baillie Gifford & Co (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Baillie Gifford & Co 18.21M sh · $1.28B · Q2 2026
- Theleme Partners LLP 8.06M sh · $564.27M · Q2 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $161.64M · Q2 2026
- Baron Funds 1.99M sh · $139.32M · Q2 2026
- BAMCO INC /NY/ 1.99M sh · $139.32M · Q2 2026
- IMC-Chicago, LLC 1.70M sh · $119.21M · Q2 2026
More on Green Alpha Advisors, LLC
FAQ
How long has Green Alpha Advisors, LLC held MRNA?
Green Alpha Advisors, LLC has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Green Alpha Advisors, LLC's current position in MRNA?
As of Q3 2026, Green Alpha Advisors, LLC holds 33.19K shares of MRNA (MODERNA INC), valued at $6.39M, representing 4.33% of its reported portfolio and ranking #4.
Has Green Alpha Advisors, LLC been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Green Alpha Advisors, LLC reduced its position in MRNA. The position peaked in Q3 2026 at 33.19K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Baillie Gifford & Co, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.